Patellar Dislocation Patients Had Lower Bone Mineral Density and Hounsfield Unit Values in the Knee Joint Compared to Patients with Anterior Cruciate Ligament Ruptures: A Focus on Cortical Bone in the Tibia.
Yue Wu, Yiting Wang, Haijun Wang, Shaowei Jia, Yingfang Ao, Xi Gong, Zhenlong Liu
{"title":"Patellar Dislocation Patients Had Lower Bone Mineral Density and Hounsfield Unit Values in the Knee Joint Compared to Patients with Anterior Cruciate Ligament Ruptures: A Focus on Cortical Bone in the Tibia.","authors":"Yue Wu, Yiting Wang, Haijun Wang, Shaowei Jia, Yingfang Ao, Xi Gong, Zhenlong Liu","doi":"10.3390/bioengineering12020165","DOIUrl":null,"url":null,"abstract":"<p><p>Anterior cruciate ligament (ACL) rupture and patellar dislocation (PD) are common knee injuries. Dual-energy X-ray absorptiometry (DXA) and computed tomography (CT) are widely used clinical diagnostic tools. The aim was to investigate the characteristics of knee bone mineral density (BMD) in patients with ACL rupture and PD and to explore the relationship between BMD and Hounsfield unit (HU) values. This prospective cross-sectional study included 32 ACL rupture and 32 PD patients assessed via DXA and CT. BMD and CT measurements were taken from regions of interest in the femoral and tibial condyles. Statistical analyses included t-tests and mixed-effects models. The results showed that BMD in the PD group was significantly lower than in the ACL group (<i>p</i> < 0.05). The HU values of cortical bone in the femur and tibia differed significantly between the ACL group and the PD group (<i>p</i> < 0.05). The BMD of the femur and tibia showed significant correlations with the HU values of cancellous bone and cortical bone (<i>p</i> < 0.05). The conclusion was that PD patients had lower BMD and HU values in the femur and tibia compared to patients with ACL ruptures, particularly in the cortical bone of the tibia, and there was a strong correlation between HU value and BMD.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 2","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11852032/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12020165","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Anterior cruciate ligament (ACL) rupture and patellar dislocation (PD) are common knee injuries. Dual-energy X-ray absorptiometry (DXA) and computed tomography (CT) are widely used clinical diagnostic tools. The aim was to investigate the characteristics of knee bone mineral density (BMD) in patients with ACL rupture and PD and to explore the relationship between BMD and Hounsfield unit (HU) values. This prospective cross-sectional study included 32 ACL rupture and 32 PD patients assessed via DXA and CT. BMD and CT measurements were taken from regions of interest in the femoral and tibial condyles. Statistical analyses included t-tests and mixed-effects models. The results showed that BMD in the PD group was significantly lower than in the ACL group (p < 0.05). The HU values of cortical bone in the femur and tibia differed significantly between the ACL group and the PD group (p < 0.05). The BMD of the femur and tibia showed significant correlations with the HU values of cancellous bone and cortical bone (p < 0.05). The conclusion was that PD patients had lower BMD and HU values in the femur and tibia compared to patients with ACL ruptures, particularly in the cortical bone of the tibia, and there was a strong correlation between HU value and BMD.
期刊介绍：
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
